Alternatives to Fluxergy

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Shift Labs develops advanced medical devices for point-of-care diagnostics and treatment.

Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.

Leveraging the adaptive immune system to diagnose and treat disease.

Global life sciences company providing diagnostic and biopharma laboratory services.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Develops advanced wound care solutions utilizing proprietary bio-active materials.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing novel immunotherapies and diagnostics for cancer.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Harnessing genetic data for digital insights in rare and germline disorders.